Literature DB >> 13916257

Purification of factor I and recognition of a third factor of the anthrax toxin.

J L STANLEY, H SMITH.   

Abstract

Entities:  

Keywords:  BACILLUS ANTHRACIS; TOXINS AND ANTITOXINS/chemistry

Mesh：

Substances：

Year:  1961        PMID： 13916257     DOI： 10.1099/00221287-26-1-49

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  74 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.

Authors:  S F Little; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen.

Authors:  Geoffrey K Feld; Alexander F Kintzer; Iok I Tang; Katie L Thoren; Bryan A Krantz
Journal:  J Mol Biol       Date:  2011-10-31       Impact factor: 5.469

4.  Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A.1.

Authors:  C G Lin; Y T Kao; W T Liu; H H Huang; K C Chen; T M Wang; H C Lin
Journal:  Curr Microbiol       Date:  1996-10       Impact factor: 2.188

5.  Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

Authors:  L C Iacono-Connors; C S Schmaljohn; J M Dalrymple
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 6.  The Pseudomonas aeruginosa Exoenzyme Y: A Promiscuous Nucleotidyl Cyclase Edema Factor and Virulence Determinant.

Authors:  K Adam Morrow; Dara W Frank; Ron Balczon; Troy Stevens
Journal:  Handb Exp Pharmacol       Date:  2017

7.  Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.

Authors:  Eric K Dumas; Lori Garman; Hannah Cuthbertson; Sue Charlton; Bassam Hallis; Renata J M Engler; Shyamal Choudhari; William D Picking; Judith A James; A Darise Farris
Journal:  Vaccine       Date:  2017-05-11       Impact factor: 3.641

8.  Neutralization of B. anthracis toxins during ex vivo phagocytosis.

Authors:  Olga Tarasenko; Ashley Scott; April Jones; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2012-09-15       Impact factor: 2.916

9.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.